BRCA1 and ovarian cancer: Any tumour that scored ≥42 or had a deleterious or suspected deleterious BRCA1/2 mutation was considered to have defective HR repair; tumours scoring <42 were considered to have functional HR repair.12 These markers reflect the degree of tumour genomic instability and are highly associated with defects in DNA repair pathway genes in ovarian cancers.